HighTower Advisors’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-10,521
| Closed | -$13K | – | 2261 |
|
2017
Q3 | $13K | Hold |
10,521
| – | – | ﹤0.01% | 2104 |
|
2017
Q2 | $17K | Buy |
+10,521
| New | +$17K | ﹤0.01% | 2053 |
|
2017
Q1 | – | Sell |
-9,138
| Closed | -$49K | – | 2082 |
|
2016
Q4 | $49K | Buy |
9,138
+1,400
| +18% | +$7.51K | ﹤0.01% | 1809 |
|
2016
Q3 | $195K | Buy |
7,738
+1,475
| +24% | +$37.2K | ﹤0.01% | 1658 |
|
2016
Q2 | $156K | Buy |
6,263
+463
| +8% | +$11.5K | ﹤0.01% | 1542 |
|
2016
Q1 | $166K | Buy |
5,800
+1,112
| +24% | +$31.8K | ﹤0.01% | 1767 |
|
2015
Q4 | $175K | Buy |
4,688
+141
| +3% | +$5.26K | ﹤0.01% | 1778 |
|
2015
Q3 | $220K | Buy |
+4,547
| New | +$220K | ﹤0.01% | 1602 |
|
2015
Q2 | – | Sell |
-5,872
| Closed | -$210K | – | 1790 |
|
2015
Q1 | $210K | Sell |
5,872
-1,162
| -17% | -$41.6K | ﹤0.01% | 1417 |
|
2014
Q4 | $89K | Buy |
+7,034
| New | +$89K | ﹤0.01% | 1481 |
|